Atlas Trials

Naxitamab and GM-CSF in People With Neuroblastoma

Clinical trial NCT04501757 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT04501757
Sponsor
Memorial Sloan Kettering Cancer Center
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
High-Risk Neuroblastoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.